Skip to content

Description of Case of Infection With a New Species of Babesia and Its Molecular Diagnosis

Description of Case of Infection With a New Species of Babesia and Its Molecular Diagnosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04960995
Acronym
BADIAG
Enrollment
1
Registered
2021-07-14
Start date
2021-07-10
Completion date
2021-07-15
Last updated
2021-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Babesiosis, Human

Keywords

Babesiosis, BABESIA, ZOONOSES

Brief summary

Babesiosis is a potentially very serious infection, but too little known. investigators want to raise their clinical colleagues and remind fellow biologists of the importance of choosing a good molecular diagnosis so as not to give false-negative results.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major subject (≥18 years old) * Splenectomized subject * Subject with severe babesiosis * Subject not having expressed, after information, his opposition to the reuse of his data for the purposes of this research

Exclusion criteria

\- Subject having expressed opposition to participating in the study

Design outcomes

Primary

MeasureTime frame
A retrospective study describing a case of infection with a new species of BabesiaThe files analyzed retrospectively concern the period from January 01, 2020 to December 31, 2020.

Countries

France

Contacts

Primary ContactAlexander PFAFF, MCU-PH
alexander.pfaff@chru-strasbourg.fr33 3 69 55 14 45
Backup ContactSaïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026